From Drug Discovery Informatics to Personalized Therapeutics

It is clear that one drug does not fit all people. The aspiration of personalized therapeutics is bringing people together through public-private collaborations from both the pharmaceutical industry and the academia. In this meeting, we will showcase the latest advancement in pre-clinical models and profiling technologies that can improve our understanding of underlying mechanism of disease from various phenotypes, as well as measurements at the genomic, metabolic and proteomic level. We will also feature IT infrastructure and bioinformatics approaches to integrate genomic and medical records data and facilitate the discovery of drug mechanisms and efficacy at the individual level.

This conference will bring together pharmacologists, biochemists, pharmacodynamics and pharmacogenomics researchers, as well as experts in data infrastructure and bioinformatics.

Connecting Electronic Health Records for Clinical Research in Europe

Mats Sundgren, Ph.D., Principal Scientist, Global Clinical Development, AstraZeneca R&D Moelndal

Community Standards, Data Curation and Sharing: Technical and Social Engineering Fundamentals

Susanna-Assunta Sansone, Ph.D., Principal Investigator, Team Leader, University of Oxford

Fast Flexible Fitting of Structure to Density Maps Using Internal Coordinates

Samuel Flores, Ph.D., Assistant Professor, Cell and Molecular Biology, Uppsala University

Early Biomarkers of Response to Cancer Treatment, Relevance of Pre-Clinical to Clinical Data

Konstantin Christov, Ph.D., Associate Professor, Surgical Oncology, University Of Illinois Chicago

Mastering Complexity of Biological Systems through Network Modularization

Corrado Priami, Ph.D., Professor, President & CEO, Microsoft Research - UNITN COSBI

Talk Title to be Announced

Andrew Hopkins, Ph.D., Professor, Biological Chemistry & Drug Discovery, University of Dundee